The recruitment automation technology developer raised the capital in a series C round led by SoftBank Vision Fund 2.

Siemens and Alphabet both backed the data warehousing platform developer in a series C1 round that hiked its overall funding to nearly $250m.

Alphabet returned to reinvest in the epigenetics diagnostics technology developer through a series D round that took its total funding to about $145m.

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.

Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

The NFT-based metaverse platform developer's latest round was led by SoftBank Vision Fund 2 and included Animoca Brands, LG Technology Ventures, Polygon Studios and Samsung Next.

Lotte Ventures was among the participants in an $88.4m round which will help the mobility platform developer increase headcount and strengthen its technology.

SoftBank Vision Fund 2 led a series C round for the progmmatic advertising software developer that increased its total funding to $105m.

Corporate-backed financial remittance network operator Lightnet netted over $48m while Callaway Golf Company invested $30m in indoor golfing chain Five Iron Golf.